News on Medial

W Health Ventures announces first close of Fund II at Rs 550 Cr

EntrackrEntrackr · 7d ago
W Health Ventures announces first close of Fund II at Rs 550 Cr
Medial

W Health Ventures announces first close of Fund II at Rs 550 Cr Healthcare focused venture capital firm W Health Ventures has announced the first close of its second fund at Rs 550 crore. The fund has a target corpus of around Rs 630 crore and will invest in 8–10 healthcare startups. The firm plans to invest in early-stage healthcare startups with cheque sizes ranging between Rs 30–50 crore. W Health Ventures follows a company-creation and incubation model, where it works with founders to build and scale healthcare businesses from inception. The new fund will focus on segments such as AI-enabled healthcare services, chronic care, preventive care, geriatrics, oncology, and other healthcare delivery models. Founded in 2019, W Health Ventures invests in healthcare startups operating across India and the US. The firm supports ventures across care delivery, digital health, and technology-led healthcare services. W Health Ventures has started deploying capital from the first close and plans to complete the final close in the coming months. Its portfolio includes healthcare startups such as Wysa, BeatO, and other digital health and care delivery ventures across India and the US.

Related News

Neo Asset Management announces fund II at Rs 2,000 Cr

EntrackrEntrackr · 10m ago
Neo Asset Management announces fund II at Rs 2,000 Cr
Medial

Neo Asset Management, a seasoned Alternative Asset Management firm in India, has announced the first close of its second flagship private credit fund - the Neo Special Credit Opportunities Fund-II (NSCOF II), at Rs 2,000 crore as on date including the first closing as filed with SEBI. Launched 3 months ago, the fund is targeting a total corpus of Rs 5,000 crore. The fund witnessed interest from Family Offices, Ultra High Net Worth Individuals (UHNIs) and Institutional Investors alike to make Neo’s journey an alternative investment platform focused on Private Credit and Real Assets. NSCOF-II is a SEBI-registered Category II AIF designed to provide bespoke credit solutions to EBITDA positive companies. As a strategy, all investments are fully covered with at least 2-3 times hard asset collateral and bear regular coupons. Neo Asset Management aims to adhere to its fund strategy and deliver returns. It looks forward to deploying capital efficiently in Fund-II. Its objective is to create a well-diversified portfolio with 25-30 investments, each ranging between Rs 150-300 crore. Neo’s first private credit, Neo Special Credit Opportunities Fund-I, closed in June 2024, raising Rs 2,575 crore. This fund has gross deployed 100% of its capital across 23 carefully curated diversified investments and have exited from 7 of these investments, over the past 18 months. The team has evaluated more than 450 investments in the last two years. Neo Group is a new-age wealth and asset management company, backed by Peak XV Partners, MUFG Bank, and Euclidean Capital and committed to building India’s leading Alternatives Asset Management platform. Neo Asset Management, the India-focused Alternative Asset Management arm of the Neo Group, manages more than Rs 10,000 crore of AUM, investing across various asset classes and delivering returns with stable cashflows.

Lavni Ventures announces first close of early stage deep-tech impact fund

EntrackrEntrackr · 6m ago
Lavni Ventures announces first close of early stage deep-tech impact fund
Medial

Lavni Ventures announces first close of early stage deep-tech impact fund Lavni Ventures has launched a Rs 200 crore deep-tech impact fund to back India’s most promising science-led startups, bringing global scale to climate, healthcare, energy, and education breakthroughs. With government-backed policies like the National Deep Tech Startup Policy and the Deep Tech Innovation Platform gaining traction, Lavni Fund II aims to ride this wave of momentum by investing in technology-driven solutions that can profitably tackle some of the world’s toughest problems. Lavni’s portfolio companies, such as Padcare Labs, Monitra Healthcare, and MedPrime Technologies, exemplify the potential of India’s deep-tech ecosystem. Collectively, Fund I startups, till FY25, have contributed to over 3.5 million student learning hours, more than 10,000 healthcare interventions in underserved markets, and 303 metric tons of CO₂ equivalent saved. “The successful launch of Fund II, with strong repeat participation from Fund I LPs, validates our core thesis: Indian deep-tech founders are uniquely positioned to deliver scalable impact and attractive returns,” said Vasu Guruswamy, co-founder and General Partner at Lavni Ventures. According to Lavni Ventures, Fund II will deploy Rs 2 crore to Rs 8 crore per opportunity at the Seed to Series A stage, and Rs 8 crore to Rs 15 crore for follow-on investments. The fund reviews over 800 deep-tech deals annually and applies a selection process focused on sustainable business models, measurable impact, and exit potential. Lavni Ventures, established in 2020 and led by Vasu Guruswamy, Sanjay Kanvinde, and Krishna Shivram, is a SEBI-registered Category II Alternative Investment Fund. It specializes in deep-tech impact investing, funding early-stage startups across medtech, edtech, cleantech, and agritech sectors.

Download the medial app to read full posts, comements and news.